Search Results - "Bräutigam, Manuel"
-
1
Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer
Published in Journal for immunotherapy of cancer (02-02-2024)“…BackgroundComprehensive profiling of autoantibodies (AAbs) in metastatic urothelial cancer (mUC) has not been performed to date. This may aid in diagnosis of…”
Get full text
Journal Article -
2
Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection
Published in Journal of translational medicine (30-12-2021)“…Pronounced sex differences in the susceptibility and response to SARS-CoV-2 infection remain poorly understood. Emerging evidence has highlighted the potential…”
Get full text
Journal Article -
3
Profiling of the antibody response to viral and bacterial antigens and its correlations with time-to-hospital discharge: Covacta and Mariposa study
Published in The Journal of immunology (1950) (01-05-2023)“…Abstract In this study the role of the humoral response to viral and bacterial antigens in hospitalised patients with severe COVID-19 and its association with…”
Get full text
Journal Article -
4
Antibody profiling of COVID-19 patients reveals antibodies and autoantibodies that may be associated with faster recovery from COVID-19
Published in The Journal of immunology (1950) (01-05-2024)“…Abstract COVID-19 infection exhibits a broad spectrum of clinical outcomes and a combination of host and viral factors interact to drive variability in…”
Get full text
Journal Article -
5
Multiplexed autoantibody (AA) profiling of patients (pts) with metastatic urothelial carcinoma (mUC) receiving immune checkpoint inhibitors or platinum-based chemotherapy
Published in Journal of clinical oncology (20-02-2022)“…Abstract only 558 Background: The AA profile may be altered in malignancies and provide insights into tumor biology and the immune state. We hypothesized that…”
Get full text
Journal Article -
6
Autoantibodies as predictors for survival and immune-related adverse events in checkpoint inhibition therapy of metastasized melanoma
Published in Journal of clinical oncology (20-05-2020)“…Abstract only 10011 Background: Increasing evidence suggests that the B cell response in cancer patients is an important component of anti-tumour immunity…”
Get full text
Journal Article -
7
Abstract 5141: Autoantibody profiling for predictive biomarkers for immune-related adverse events and clinical benefit in rare tumors treated with anti-PD-1 therapy
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract Background: Immune checkpoint inhibitors (ICIs) have changed the cancer treatment paradigm; however, with high frequency of immune-related adverse…”
Get full text
Journal Article -
8
Abstract 2269: Bexmarilimab induces B-cell activation and autoantibody production
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Introduction: Bexmarilimab, a Clever-1 targeting humanized antibody, is a macrophage checkpoint inhibitor promoting antigen presentation and…”
Get full text
Journal Article